Shandong Buchang Pharmaceuticals Co., Ltd.
SHH: 603858.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Chao Zhao
- Employees
- 8,311
- Headquarters
- Heze, China
- IPO year
- 2016
- Market cap
- CN¥17.0B
- Website
- https://www.buchang.com
Loading 603858…
Loading profile data…Frequently asked questions about 603858
What does Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) do?
Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China. Shando...
Where does 603858.SS trade?
Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) trades on the Shanghai Stock Exchange.
What sector is 603858.SS in?
Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shandong Buchang Pharmaceuticals Co., Ltd.?
Chao Zhao is the chief executive officer of Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS).
Where is Shandong Buchang Pharmaceuticals Co., Ltd. headquartered?
Shandong Buchang Pharmaceuticals Co., Ltd. is headquartered in China.
Does 603858.SS pay a dividend?
Yes — Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) paid a trailing twelve-month dividend of CNY 0.39 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603858.SS go public?
Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) completed its initial public offering in 2016.